Adenosine and cAMP signalling skew human dendritic cell differentiation towards a tolerogenic phenotype with defective CD8+ T-cell priming capacity

Immunology

Volumn 138, Issue 4, 2013, Pages 402-410

  Challier, John ^a   Bruniquel, Denis ^a   Sewell, Andrew K ^b   Laugel, Bruno ^a,b  

^a MERCK SERONO S A   (Switzerland)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Adenosine; Dendritic cells; Immunomodulation; T cell priming

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; CYCLIC AMP; TUMOR ANTIGEN;

ARTICLE; BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENOSINE; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; IMMUNOLOGIC FACTORS; MONOCYTES; PERIPHERAL TOLERANCE; PHENOTYPE; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 84874962962     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12053     Document Type: Article

References (49)

1. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, Voehringer D. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206:549-59.
2. Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 2006; 312:1672-6.
3. Lopez-Bravo M, Ardavin C. In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 2008; 29:343-51.
4. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006; 124:849-63.
5. Merad M, Manz MG. Dendritic cell homeostasis. Blood 2009; 113:3418-27.
6. Leon B, Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol 2008; 86:320-4.
7. Ginhoux F, Tacke F, Angeli V et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006; 7:265-73.
8. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994; 179:1109-18.
9. Chorny A, Gonzalez-Rey E, Delgado M. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation. Ann N Y Acad Sci 2006; 1088:187-94.
10. Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev 2004; 4:24-34.
11. Hughes GC, Clark EA. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 2007; 40:470-81.
12. Newby AC, Worku Y, Holmquist CA. Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 1985; 6:273-84.
13. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004; 22:657-82.
14. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev 2008; 7:759-70.
15. Ohta A, Sitkovsky M. The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol 2009; 9:501-6.
16. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414:916-20.
17. Gessi S, Fogli E, Sacchetto V, Varani K, Merighi S, Leung E, Lennan SM, Borea PA. Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. Biochem Pharmacol 2008; 75:562-9.
18. Kumar V, Sharma A. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 2009; 616:7-15.
19. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK. HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 2008; 111:5571-80.
20. Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 2005; 26:299-304.
21. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 2008; 14:5947-52.
22. Jin D, Fan J, Wang L et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245-55.
23. Nemeth ZH, Csoka B, Wilmanski J et al. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol 2006; 176:5616-26.
24. Thammavongsa V, Kern JW, Missiakas DM, Schneewind O. Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med 2009; 206:2417-27.
25. Oliveira CJ, Sa-Nunes A, Francischetti IM et al. Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties. J Biol Chem 2011; 286:10960-9.
26. Carregaro V, Sa-Nunes A, Cunha TM et al. Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions. J Immunol 2011; 187:4347-59.
27. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR. The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn. J Immunol 2006; 177:1956-66.
28. Raskovalova T, Huang X, Sitkovsky M, Zacharia LC, Jackson EK, Gorelik E. Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells. J Immunol 2005; 175:4383-91.
29. + T lymphocytes by adenosine-protein kinase A type I signaling. Cancer Res 2007; 67:5949-56.
30. Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter PJ, Mrowietz U, Dichmann S, Norgauer J. Expression and function of adenosine receptors in human dendritic cells. FASEB J 2001; 15:1963-70.
31. Schnurr M, Toy T, Shin A et al. Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 2004; 103:1391-7.
32. Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A, Girolomoni G, Norgauer J. Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 2003; 101:3985-90.
33. Cole DK, Yuan F, Rizkallah PJ et al. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J Biol Chem 2009; 284:27281-9.
34. Novitskiy SV, Ryzhov S, Zaynagetdinov R et al. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 2008; 112:1822-31.
35. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med 1999; 190:705-15.
36. Driesen J, Popov A, Schultze JL. CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology 2008; 213:849-58.
37. Vlad G, Chang CC, Colovai AI, Berloco P, Cortesini R, Suciu-Foca N. Immunoglobulin-like transcript 3: a crucial regulator of dendritic cell function. Hum Immunol 2009; 70:340-4.
38. Krishnamoorthy N, Oriss TB, Paglia M, Fei M, Yarlagadda M, Vanhaesebroeck B, Ray A, Ray P. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 2008; 14:565-73.
39. Chen M, Wang J. Programmed cell death of dendritic cells in immune regulation. Immunol Rev 2010; 236:11-27.
40. Stranges PB, Watson J, Cooper CJ et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 2007; 26:629-41.
41. Romagnani S, Maggi E, Liotta F, Cosmi L, Annunziato F. Properties and origin of human Th17 cells. Mol Immunol 2009; 47:3-7.
42. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685-711.
43. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006; 108:1435-40.
44. Munn DH, Sharma MD, Lee JR et al. Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase. Science 2002; 297:1867-70.
45. 2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006; 108:228-37.
46. Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med (Berl) 2008; 86:145-60.
47. Thomson AW. Tolerogenic dendritic cells: all present and correct? Am J Transplant 2010; 10:214-9.
48. Ohta A, Gorelik E, Prasad SJ et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 2006; 103:13132-7.
49. + T cells. Eur J Immunol 2012; 43:85-92.